Acute lymphoblastic leukemia cells that survive combination chemotherapy in vivo remain sensitive to allogeneic immune effects
Authors:
- 1 June 2011
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 35 (6) , 800-807
Abstract
No abstract availableKeywords
Funding Information
- St. Baldrick's Foundation
- the National Institutes of Health
- Brockport High School Leukemia Dance Marathon
This publication has 33 references indexed in Scilit:
- Targeting p53 for enhanced radio- and chemo-sensitivityApoptosis, 2009
- Allogeneic Transplantation for Pediatric Acute Lymphoblastic Leukemia: The Emerging Role of Peritransplantation Minimal Residual Disease/Chimerism Monitoring and Novel Chemotherapeutic, Molecular, and Immune Approaches Aimed at Preventing RelapseTransplantation and Cellular Therapy, 2009
- High-Risk Acute Lymphoblastic Leukemia Cells with bcr-abl and Ink4a/Arf Mutations Retain Susceptibility to Alloreactive T CellsTransplantation and Cellular Therapy, 2008
- A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: Comparisons to a 4 h 51Cr-release assayJournal of Immunological Methods, 2007
- Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2Blood, 2006
- Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group studyBlood, 2006
- Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemiaEuropean Journal of Cancer, 2006
- Cellular tumor vaccines administered after T cell-depleted allogeneic bone marrow transplantation induce effective anti-tumor immune responsesLeukemia & Lymphoma, 2005
- Analysis of immunodominance among minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantationBone Marrow Transplantation, 2003
- Influence of Tumor Vaccines on Graft Versus Tumor Activity and Graft Versus Host Disease in Allogeneic Bone Marrow TransplantationLeukemia & Lymphoma, 2002